Christopher Schaber

Directeur Général chez SOLIGENIX, INC.

Fortune : 6 142 $ au 30/06/2026

59 ans

63 relations

Health Technology

Consumer Services

Commercial Services

Profil

Dr. Christopher J.
Schaber is a Member-Corporate Council at The National Organization for Rare Disorders, Inc., a Member-Corporate Council at American Society for Blood & Marrow Transplantation and a Chairman, President & Chief Executive Officer at Soligenix, Inc. He is on the Board of Directors at Simphotek, Inc., Alliance for Biosecurity and BioNJ, Inc. Dr. Schaber was previously employed as a Chief Operating Officer & Executive Vice President by Discovery Laboratories, Inc., a Chief Operating Officer & Executive Vice President by Discovery Laboratories, Inc., a VP-Regulatory Compliance & Drug Development by Acute Therapeutics, Inc., and a Worldwide Director-Regulatory Affairs & Operations by Ohmeda PPD, Inc. He also served on the board at BioSecurity Technologies, Inc. He received his undergraduate degree from McDaniel College, a graduate degree from Temple University School of Pharmacy and a doctorate degree from Union Institute & University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
SOLIGENIX, INC. 0,1 %	11/12/2025	15 511 ( 0,1 % )	6 142 $	30/06/2026

Postes actifs de Christopher Schaber

Sociétés	Poste	Début
SOLIGENIX, INC.	Directeur Général	01/08/2006
The National Organization for Rare Disorders, Inc. The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services	Corporate Officer/Principal	17/08/2010
American Society for Blood & Marrow Transplantation American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs.	Corporate Officer/Principal	01/07/2009
Alliance for Biosecurity	Directeur/Membre du Conseil	01/10/2014
BioNJ, Inc. BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey	Directeur/Membre du Conseil	-
Simphotek, Inc. Simphotek, Inc. Medical SpecialtiesHealth Technology Develops dosimetry devices for cancer treatments	Directeur/Membre du Conseil	01/06/2018

Tous les postes actifs de Christopher Schaber

Anciens postes connus de Christopher Schaber

Sociétés	Poste	Fin
WINDTREE THERAPEUTICS, INC.	Directeur des opérations	01/01/2006
Discovery Laboratories, Inc. Discovery Laboratories, Inc. Part of Windtree Therapeutics, Inc., Discovery Laboratories, Inc. is an American company that specializes in the development of drug products for patients with respiratory disease. The company, now known as Windtree Technologies, Inc., was established in 1992 and is based in Warrington, PA. The company's main products include Surfaxin, a synthetic, peptide-containing surfactant that is delivered to the lung using capillary aerosol-generating technology, and Aerosurf, a drug-device combination designed to prevent respiratory distress syndrome in premature infants. Additionally, the company offers Afectair devices, disposable aerosol airway connectors.	Directeur des opérations	01/01/2006
Acute Therapeutics, Inc.	Fondateur	01/01/1998
░░░░░░ ░░░░ ░░░░	░░░░░░░░░ ░░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-

Voir l'expérience en détail de Christopher Schaber

Formation de Christopher Schaber

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher Schaber

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	14
Soligenix, Inc. Soligenix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes biodefense vaccines and oral therapeutic products	Health Technology
Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets	Health Technology
BioSecurity Technologies, Inc. BioSecurity Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Acquires intellectual properties	Commercial Services
Simphotek, Inc. Simphotek, Inc. Medical SpecialtiesHealth Technology Develops dosimetry devices for cancer treatments	Health Technology
McDaniel College McDaniel College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Union Institute & University Union Institute & University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Acute Therapeutics, Inc.
The National Organization for Rare Disorders, Inc. The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services	Health Services
American Society for Blood & Marrow Transplantation American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs.
Ohmeda PPD, Inc.
BioNJ, Inc. BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey	Commercial Services
Alliance for Biosecurity
Temple University School of Pharmacy Temple University School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Discovery Laboratories, Inc. Discovery Laboratories, Inc. Part of Windtree Therapeutics, Inc., Discovery Laboratories, Inc. is an American company that specializes in the development of drug products for patients with respiratory disease. The company, now known as Windtree Technologies, Inc., was established in 1992 and is based in Warrington, PA. The company's main products include Surfaxin, a synthetic, peptide-containing surfactant that is delivered to the lung using capillary aerosol-generating technology, and Aerosurf, a drug-device combination designed to prevent respiratory distress syndrome in premature infants. Additionally, the company offers Afectair devices, disposable aerosol airway connectors.